21
JW Therapeutics
2126.HK·HKEXShanghai CNFounded 2016300 employees
Small CapbiotechPublicOncologyHematology
Platform: CAR-T CN
Market Cap
$0.3B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (2126.HK)
Loading 2126.HK stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Lisozasiran | 212-4904 | Phase 1 | 1 | KRASG12C | Angelman | ||
| 212-6798 | 212-6798 | Phase 1/2 | 1 | CD19 | Breast CaParkinson's |
SEC Filings & Financial Documents
SEC filings are not available for HKEX-listed companies.
JW Therapeutics trades on HKEX (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)